Injection Depth and Angle Ozempic and other GLP-1 pens are designed for subcutaneous use
Sharing a 94% structural homology with native human GLP-1, Semaglutide is distinguished by three modifications: 1) amino-acid substitutions at position 8 (alanine to -aminoisobutyric acid or Aib) and position 34 (lysine to arginine), and acylation of the lysine in position 26 with a spacer consisting of two 8-amino-3,6-dioxaoctanoic acid (ADO) moieties, a glutamic acid moiety, and a C-18 fatty di-acid side chain (Lau et al., 2015)
Cauliflower rice keeps net carbs low without sacrificing satisfaction, ideal for the smaller portions that tirzepatide naturally creates
Individuals commencing Ozempic should understand: The importance of adequate calcium and vitamin D intake through diet and supplementation if indicated The value of regular physical activity in line with UK guidance (at least 150 minutes of moderate intensity activity weekly, plus strength exercises on 2 days per week) The need to report any bone pain, fractures, or significant height loss That gradual, sustained weight loss is preferable to rapid reduction The overall safety profile of the medication and no evidence of direct bone toxicity The importance of reporting suspected side effects via the MHRA Yellow Card Scheme Lifestyle interventions should be emphasised as integral to treatment success
